Mylan Sues FDA For Delaying Duragesic Generic
Mylan Laboratories Inc. has sued the U.S. Food and Drug Administration for delaying introduction of the company's generic version of Johnson & Johnson's Duragesic pain-relief skin patch....To view the full article, register now.
Already a subscriber? Click here to view full article